The role of a glycoprotein K (gK) CD8 +T-Cell epitope of herpes simplex virus on virus replication and pathogenicity

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 6, 2009, Pages 2903-2912

  Mott, Kevin R ^a   Chentoufi, Aziz A ^b   Carpenter, Dale ^c   Benmohamed, Lbachir ^b   Wechsler, Steven L ^c   Ghiasi, Homayon ^a  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; EYE DROPS; GAMMA INTERFERON; GLYCOPROTEIN B; GLYCOPROTEIN K; GRANZYME A; GRANZYME B; HLA A ANTIGEN; ISOLEUCYLTHREONYLALANYLTYROSYLGLYCYLLEUCYLVALYLLEUCINE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; UNCLASSIFIED DRUG; LAMP1 PROTEIN, MOUSE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; PEPTIDE FRAGMENT; UL53 PROTEIN, HUMAN HERPESVIRUS 1; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CORNEA; CORNEAL SCARRING; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE INFECTION; FEMALE; HERPES SIMPLEX VIRUS; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SURVIVAL; TRANSGENIC MOUSE; TRIGEMINUS GANGLION; VIRUS REPLICATION; VIRUS VIRULENCE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CYTOTOXICITY; DISEASE MODEL; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; IMMUNOLOGY; MOUSE; PATHOGENICITY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CORNEA; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; FEMALE; HERPESVIRUS 1, HUMAN; IMMUNIZATION; INTERFERON-GAMMA; KERATITIS, HERPETIC; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OPHTHALMIC SOLUTIONS; PEPTIDE FRAGMENTS; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 66849083525     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2957     Document Type: Article

References (55)

1. Dawson CR. Ocular herpes simplex virus infections. Clin Dermatol. 1984;2:56-66.
2. Barron BA, Gee L, Hauck WW, et al. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology. 1994;101:1871-1882.
3. Wilhelmus KR, Dawson CR, Barron BA, et al. Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group. Br J Ophthalmol. 1996;80:969-972.
4. Binder PS. A review of the treatment of ocular herpes simplex infections in the neonate and immunocompromised host. Cornea. 1984;3:178-182.
5. Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea. 2001;20:1-13.
6. Metcalf JF, Kaufman HE. Herpetic stromal keratitis-evidence for cell-mediated immunopathogenesis. Am J Ophthalmol. 1976;82: 827-834.
7. Thomas J, Rouse BT. Immunopathogenesis of herpetic ocular disease. Immunol Res. 1997;16:375-386.
8. Ksander BR, Hendricks RL. Cell-mediated immune tolerance to HSV-1 antigens associated with reduced susceptibility to HSV-1 corneal lesions. Invest Ophthalmol Vis Sci. 1987;28:1986-1993.
9. McGeoch DJ, Dalrymple MA, Davison AJ, et al. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol. 1988;69:1531-1574.
10. Hutchinson L, Goldsmith K, Snoddy D, Ghosh H, Graham FL, Johnson DC. Identification and characterization of a novel herpes simplex virus glycoprotein, gK, involved in cell fusion. J Virol. 1992;66:5603-5609.
11. Ghiasi H, Slanina S, Nesburn AB, Wechsler SL. Characterization of baculovirus-expressed herpes simplex virus type 1 glycoprotein K. J Virol. 1994;68:2347-2354.
12. Debroy C, Pederson N, Person S. Nucleotide sequence of a herpes simplex virus type 1 gene that causes cell fusion. Virology. 1985; 145:36-48.
13. Bond VC, Person S. Fine structure physical map locations of alterations that affect cell fusion in herpes simplex virus type 1. Virology. 1984;132:368-376.
14. Little SP, Schaffer PA. Expression of the syncytial (syn) phenotype in HSV-1, strain KOS: genetic and phenotypic studies of mutants in two syn loci. Virology. 1981;112:686-702.
15. Pogue-Geile KL, Spear PG. The single base pair substitution responsible for the Syn phenotype of herpes simplex virus type 1, strain MP. Virology. 1987;157:67-74.
16. Foster TP, Kousoulas KG. Genetic analysis of the role of herpes simplex virus type 1 glycoprotein K in infectious virus production and egress. J Virol. 1999;73:8457-8468.
17. Hutchinson L, Johnson DC. Herpes simplex virus glycoprotein K promotes egress of virus particles. J Virol. 1995;69:5401-5413.
18. Hutchinson L, Roop-Beauchamp C, Johnson DC. Herpes simplex virus glycoprotein K is known to influence fusion of infected cells, yet is not on the cell surface. J Virol. 1995;69:4556-4563.
19. Ghiasi H, Bahri S, Nesburn AB, Wechsler SL. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins. Invest Ophthalmol Vis Sci. 1995;36:1352-1360.
20. Ghiasi H, Kaiwar R, Nesburn AB, Slanina S, Wechsler SL. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J Virol. 1994;68:2118-2126.
21. Ghiasi H, Cai S, Slanina S, Nesburn AB, Wechsler SL. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations. Invest Ophthalmol Vis Sci. 1997;38:1213-1221.
22. Osorio Y, Cai S, Hofman FM, Brown DJ, Ghiasi H. Involvement of CD8 T cells in exacerbation of corneal scarring in mice. Curr Eye Res. 2004;29:145-151.
23. Osorio Y, Mott KR, Jabbar AM, et al. Epitope mapping of HSV-1 glycoprotein K (gK) reveals a T cell epitope located within the signal domain of gK. Virus Res. 2007;128:71-80.
24. McGeoch DJ, Cunningham C, McIntyre G, Dolan A. Comparative sequence analysis of the long repeat regions and adjoining parts of the long unique regions in the genomes of herpes simplex viruses types 1 and 2. J Gen Virol. 1991;72:3057-3075.
25. Dolan A, Jamieson FE, Cunningham C, Barnett BC, McGeoch DJ. The genome sequence of herpes simplex virus type 2. J Virol. 1998;72:2010-2021.
26. Mott KR, Perng GC, Osorio Y, Kousoulas KG, Ghiasi H. A recombinant herpes simplex virus type 1 expressing two additional copies of gK is more pathogenic than wild-type virus in two different strains of mice. J Virol. 2007;81:12962-12972.
27. David AT, Baghian A, Foster TP, Chouljenko VN, Kousoulas KG. The herpes simplex virus type 1 (HSV-1) glycoprotein K(gK) is essential for viral corneal spread and neuroinvasiveness. Curr Eye Res. 2008;33:455-467.
28. Firat H, Garcia-Pons F, Tourdot S, et al. H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies. Eur J Immunol. 1999;29:3112-3121.
29. Chentoufi AA, Zhang X, Lamberth K, et al. HLA-A*0201-restricted CD8 cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D. J Immunol. 2008;180:426-437.
30. Betts MR, Brenchley JM, Price DA, et al. Sensitive and viable identification of antigen-specific CD8 T cells by a flow cytometric assay for degranulation. J Immunol Methods. 2003;281:65-78.
31. Mott KR, Osorio Y, Brown DJ, et al. The corneas of naive mice contain both CD4 and CD8 T cells. Mol Vis. 2007;13:1802-1812.
32. Ghiasi H, Kaiwar R, Nesburn AB, Wechsler SL. Expression of herpes simplex virus type 1 glycoprotein B in insect cells. Initial analysis of its biochemical and immunological properties. Virus Res. 1992;22:25-39.
33. Mott KR, Osorio Y, Maguen E, et al. Role of anti-glycoproteins D (anti-gD) and K (anti-gK) IgGs in pathology of herpes stromal keratitis in humans. Invest Ophthalmol Vis Sci. 2007;48:2185-2193.
34. Betts MR, Koup RA. Detection of T-cell degranulation: CD107a and b. Methods Cell Biol. 2004;75:497-512.
35. Mittendorf EA, Storrer CE, Shriver CD, Ponniah S, Peoples GE. Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8 cells recognizing HER2/neu vaccine peptides. Breast Cancer Res Treat. 2005;92:85-93.
36. Ghiasi H, Cai S, Slanina S, Nesburn AB, Wechsler SL. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge. Antiviral Res. 1995;28:147-157.
37. McGuffin LJ, Bryson K, Jones DT. The PSIPRED protein structure prediction server. Bioinformatics. 2000;16:404-405.
38. Citron M, Diehl TS, Gordon G, Biere AL, Seubert P, Selkoe DJ. Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities. Proc Natl Acad Sci U S A. 1996;93: 13170-13175.
39. Wildner G, Diedrichs-Mohring M. Autoimmune uveitis induced by molecular mimicry of peptides from rotavirus, bovine casein and retinal S-antigen. Eur J Immunol. 2003;33:2577-2587.
40. DeMager PP, Penke B, Walter R, Harkany T, Hartignny W. Pathological peptide folding in Alzheimer's disease and other conformational disorders. Curr Med Chem. 2002;9:1763-1780.
41. Namba K, Ogasawara K, Kitaichi N, et al. Amelioration of experimental autoimmune uveoretinitis by pretreatment with a pathogenic peptide in liposome and anti-CD40 ligand monoclonal antibody. J Immunol. 2000;165:2962-2969.
42. Fukushima A, Nishino K, Yoshida O, Ueno H. Characterization of the immunopathogenic responses to ovalbumin peptide 323-339 in experimental immune-mediated blepharoconjunctivitis in Lewis rats. Curr Eye Res. 1998;17:763-769.
43. Dawe KI, Hutchings PR, Geysen M, Champion BR, Cooke A, Roitt IM. Unique role of thyroxine in T cell recognition of a pathogenic peptide in experimental autoimmune thyroiditis. Eur J Immunol. 1996;26:768-772.
44. Rao VP, Balasa B, Carayanniotis G. Mapping of thyroglobulin epitopes: presentation of a 9mer pathogenic peptide by different mouse MHC class II isotypes. Immunogenetics. 1994;40:352-359.
45. Fling SP, Gold DP, Gregerson DS. Multiple, autoreactive TCR V beta genes utilized in response to a small pathogenic peptide of an autoantigen in EAU. Cell Immunol. 1992;142:275-286.
46. Lepisto AJ, Frank GM, Xu M, Stuart PM, Hendricks RL. CD8 T cells mediate transient herpes stromal keratitis in CD4-deficient mice. Invest Ophthalmol Vis Sci. 2006;47:3400-3409.
47. Neumann H, Medana IM, Bauer J, Lassmann H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 2002;25:313-319.
48. Huseby ES, Liggitt D, Brabb T, Schnabel B, Ohlen C, Goverman J. A pathogenic role for myelin-specific CD8()Tcellsinamodelfor multiple sclerosis. J Exp Med. 2001;194:669-676.
49. Sun D, Whitaker JN, Huang Z, et al. Myelin antigen-specific CD8 T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol. 2001;166:7579-7587.
50. Osorio Y, La Point SF, Nusinowitz S, Hofman FM, Ghiasi H. CD8 - dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2. Exp Neurol. 2005;193:1-18.
51. Henkart PA, Williams MS, Nakajima H. Degranulating cytotoxic lymphocytes inflict multiple damage pathways on target cells. Curr Top Microbiol Immunol. 1995;198:75-93.
52. Kagi D, Ledermann B, Burki K, Zinkernagel RM, Hengartner H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol. 1996;14:207-232.
53. Matloubian M, Suresh M, Glass A, et al. A role for perforin in downregulating T-cell responses during chronic viral infection. J Virol. 1999;73:2527-2536.
54. Ghiasi H, Cai S, Perng G, Nesburn AB, Wechsler SL. Perforin pathway is essential for protection of mice against lethal ocular HSV-1 challenge but not corneal scarring. Virus Res. 1999;65:97-101.
55. Maertzdorf J, Verjans GM, Remeijer L, van der Kooi A, Osterhaus AD. Restricted T cell receptor beta-chain variable region protein use by cornea-derived CD4 and CD8 herpes simplex virus-specific T cells in patients with herpetic stromal keratitis. J Infect Dis. 2003;187:550-558.